Support for Patient Organisations

Boehringer Ingelheim recognises that it has many common interests with organisations which represent or support the needs of patients and caregivers. We form these meaningful partnerships to help improve the health and quality of life of patients and raise awareness of health issues and conditions.

As a company, we remain committed to the principle of reporting accurate, fair and objective information about our collaboration with Health Consumer Organisations and support the Medicines Australia 'Working Together' partnerships guide.

Boehringer Ingelheim supports patient organisations

Health Consumer Organisations, or patient groups, are not-for-profit organisations that represent the interests and views of patients and/or caregivers and consumers of healthcare.

In 2016, Boehringer Ingelheim Australia worked with the following Health Consumer Organisations:

Organisation Name Our Support in 2016 $
Australian Pituitary Foundation Boehringer Ingelheim is proud to provide sponsorship towards the development of the new Australian Pituitary Foundation website. $4,545.00.
Cancer Council

Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising efforts. Boehringer Ingelheim was proud to support Cancer Council through this program.

$6,087.00.
Children's Cancer Council

Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising efforts. Boehringer Ingelheim was proud to support Children's Cancer Council through this program.

 $918.00.
Kidney Health Australia

Boehringer Ingelheim is proud to provide sponsorship to support the delivery of independent, high quality ongoing face-face and digital medical education programs on chronic kidney disease and diabetes that will be rolled-out in 2017.

 $40,000.00.
Lung Foundation Australia

Boehringer Ingelheim is a proud supporter of the Lung Foundation Australia. It is a national organisation which was originally established as The Australian Lung Foundation in 1990 to provide support to patients and carers burdened by lung disease and to ensure lung health is a priority for all in Australia. They do this through the provision of a range of successful, fundraising, advocacy, education and support programs.

Over 2016 the company supported a range of initiatives including:

  • Boehringer Ingelheim is a Foundation Sponsor and contributed an unrestricted donation of $140,000 to allow the Lung Foundation to carry out their COPD program which includes patient advocacy, disease awareness and HCP guidance and educational materials.
  • Boehringer Ingelheim proudly provides an unrestricted sponsorship for a 2 year COPD Research Fellowship Award, awarded annually to a researcher in COPD who fulfills criteria set out and judged by the Lung Foundation Australia.in 2016, the company provided $160,000 p.a (which is made up of 2 x $80,000 awards. One for the 2nd year of the fellowship awarded in 2015, and then one for the 1st year of the newly awarded fellowship in 2016).
  • Boehringer Ingelheim provided funds for the development of a video about the COPD Research Fellowship Award and the past participants to help attract future applicants.
  • Boehringer Ingelheim is a proud sponsor of the Idiopathic Pulmonary Fibrosis Registry. The company contributed funds of $75,000 via an unrestricted donation to allow the Lung Foundation to carry out their Idiopathic Pulmonary Fibrosis patient registry and conduct research into patients with this rare disease.
  • Boehringer Ingelheim is proud to provide sponsorship for the Bridging Regional Gaps – Lung Cancer Workshop held in Tasmania.  This one day Lung Cancer Workshop was for all lung cancer health professionals to further understand the disease and reduce the impact of Lung Cancer on patients, carers and their families.
     
  • Boehringer Ingelheim was proud to be a major sponsor of the Lung Foundation Gala Dinner. This fundraising event raised funds to provide essential services and resources for patients, families, health professionals and everyone affected by lung disease. The Company provided $20, 000 for the sponsorship.

 

 

 

 

 

 

 

$140,000.00.

 

 

$160,000.00.

 

 

 

 

 

$31,000.00.

 

 

$75,000.00.

 

 

 

$2,500.00.

 

 

 

$20,000.00.
National Asthma Council

Over 2016 the company supported a range of initiatives including:

  • Sponsorship for the review of the educational asthma content for the Australian healthcare professionals’ area of the website  www.lunglearning.com.au
     
  • Sponsorship for the production of an instructional video on how to correctly use the Respimat inhaler, published on the National Asthma Council website in the existing ‘How-to’ video library.
     
  • Sponsorship of the revision and updating of the 2016 Asthma & COPD Medications Chart for Australian healthcare professionals

 

 

$2,900.00.

 

 

$6,800.00.

 

 

$17,000.00
The Stroke Foundation

Boehringer Ingelheim proudly provided part sponsorship towards the update The Deloitte Access Economics Report - Impact of Stroke Across Australia

Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising efforts. Boehringer Ingelheim was proud to support The Stroke Foundation through this program.

$42,000.00.

 

$1,182.00.